Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBC) Net Margin (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Net Margin for 3 consecutive years, with 29.6% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Margin rose 2426.0% year-over-year to 29.6%, compared with a TTM value of 25.48% through Sep 2025, up 203.0%, and an annual FY2024 reading of 22.73%, up 2257.0% over the prior year.
  • Net Margin was 29.6% for Q3 2025 at SBC Medical Group Holdings, up from 5.63% in the prior quarter.
  • Across five years, Net Margin topped out at 4401.2% in Q4 2023 and bottomed at 0.53% in Q1 2024.
  • Average Net Margin over 3 years is 515.41%, with a median of 29.37% recorded in 2024.
  • The sharpest move saw Net Margin plummeted -438161bps in 2024, then skyrocketed 4594bps in 2025.
  • Year by year, Net Margin stood at 4401.2% in 2023, then crashed by -100bps to 19.59% in 2024, then soared by 51bps to 29.6% in 2025.
  • Business Quant data shows Net Margin for SBC at 29.6% in Q3 2025, 5.63% in Q2 2025, and 45.41% in Q1 2025.